Through an Innovate UK-funded grant project,has designed a tool to help doctors discern the appropriate amount of chemotherapy for a particular patient.
Physiomics completed the tool last month with the aid of £68,000 from the Innovate UK grant.
Normally, doctors administer a similar dosage to patients, but when considering the variability of each patient’s response to the drug this can often lead to under- or over-dosing of the chemotherapy.
However, Physiomics’ new tool uses blood tests to give clinicians a better insight into the toxicity and efficacy of a given dose, therefore allowing them to optimize treatment for the individual patient.
And, the company believes there is “nearer term revenue potential” than might be expected from a medical device likely to be subjected to further clinical validation, arguing it could be used earlier in research settings.
Moreover, the tool is likely to reduce costs and health detriments, such as toxicity, associated with over-dosing chemotherapy as well as avoid the decreased efficacy that comes with under-dosing.
The company hopes to begin the commercialization process quickly and is currently approaching potential strategic partners, clinical collaborators and grant providers to that end.
For more news and updates on Physiomics:
Tlou's Managing Director, Mr Tony Gilby said “The Company will now progress with additional work on the ground to deliver a Gas-to-Power solution that can bring significant benefits to the country and to our shareholders. I look forward to updating the market as we continue to develop the project."
Tone Goh, Executive Chairman of GST, commented: "The Company is delighted to have signed this LOI with SIAM. SIAM are one of Thailand's leading business groups and we look forward to working with them to progress this planned data centre project.”
Five financial stories, trending today in a 60 second podcast, including: Google has barred phone maker Huawei off from receiving some updates to the Android operating system, dealing a blow to the Chinese firm and their new smartphones will also lose access to popular Google apps. The move comes after the Trump administration added Huawei to a list of companies that American firms cannot trade with unless they have a licence.
On today's podcast: Glen Goodman author of, "The Crypto Trader", talks about the recent rise, fall and rise again of Bitcoin. Russ Mould covers Stock Spirits, Nichols & Vodafone. Alan Green talks about: Cadence Minerals, RA International & BigDish.
SP Angel research note on commodities and miners, featuring: Anglo Asian Mining* (AAZ LN) BUY – 126p – Earnings update African Battery Metals* (ABM LN) – Kisinka copper-cobalt project field programme completed BlueRock Diamonds* (BRD LN) – Funding raised to implement new mine plan Pan African Resources (PAF LN) – Q3 results on track to meet guidance of 170,000oz of gold production